Rockefeller Capital Management
RLYB icon

Rockefeller Capital Management’s Rallybio RLYB Stock Holding History

Rockefeller Capital Management’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-69
Closed -$274 – 4816
2025
Q3 		$274 Buy
+69
New +$290 ﹤0.01% 4333

Other funds holding RLYB

AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Rockefeller Capital Management's RLYB Position: Q4 2025 in Review

Rockefeller Capital Management sold out of Rallybio (RLYB) in Q4 2025, closing a stake of 69 shares — an estimated $274 sold.

Rockefeller Capital Management first reported a position in RLYB in Q3 2025 and held it in 1 quarter. The position peaked at $274 in Q3 2025. 46 funds tracked by Wall St. Rank hold RLYB as of Q4 2025.

  • Rockefeller Capital Management reported no remaining Rallybio position as of Q4 2025 after selling out during the quarter.
  • Rockefeller Capital Management sold 69 Rallybio shares in Q4 2025, an estimated $274.
  • Rockefeller Capital Management first reported a position in Rallybio in Q3 2025 and held it in 1 quarter.
  • Rockefeller Capital Management's Rallybio position peaked at $274 in Q3 2025.
  • 46 funds tracked by Wall St. Rank held Rallybio as of Q4 2025.

Based on Rockefeller Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.